Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$2.34 - $6.41 $33,560 - $91,932
-14,342 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$4.15 - $8.86 $249 - $531
-60 Reduced 0.42%
14,342 $86,000
Q3 2021

Nov 15, 2021

SELL
$7.66 - $16.11 $4,864 - $10,229
-635 Reduced 4.22%
14,402 $112,000
Q2 2021

Aug 16, 2021

BUY
$11.44 - $13.57 $172,023 - $204,052
15,037 New
15,037 $204,000

Others Institutions Holding ELEV

About Elevation Oncology, Inc.


  • Ticker ELEV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,300,900
  • Market Cap $14M
  • Description
  • Elevation Oncology, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of cancer in genomically defined patient populations in the United States. The company's lead program is the seribantumab, an anti-HER3 monoclonal antibody that is in Phase II CRESTONE trial for the treatment of advanced sol...
More about ELEV
Track This Portfolio

Track Weiss Multi Strategy Advisers LLC Portfolio

Follow Weiss Multi Strategy Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Weiss Multi Strategy Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Weiss Multi Strategy Advisers LLC with notifications on news.